RxDoctor Payments DataLook up a doctor →

EPKINLY: payments to doctors

Payments that named EPKINLY as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$5.2M
Providers
12,888
Transactions
48,695
Average per transaction
$107

The per-transaction average — $107 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 12,888 providers the average total is $403, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Genmab U.S., Inc.$2,723,30652.4%
AbbVie$2,387,50645.9%
Pharmacyclics LLC, An Abbvie Company$87,8251.7%
Genmab A/s$3500.0%
← All drugs & devices